Lenvervimab
Modify Date: 2024-01-11 11:00:16
Lenvervimab structure
|
Common Name | Lenvervimab | ||
|---|---|---|---|---|
| CAS Number | 2055006-79-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LenvervimabLenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2]. |
| Name | Lenvervimab |
|---|
| Description | Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Lenvervimab (1 nM-1 μM，16 小时) 抑制感染 HBV 的 HepG2-NTCP 细胞中的 HBV 感染[1]。 Lenvervimab 可识别 HBV 感染的许多病毒基因型和临床变异体[1]。 Western Blot Analysis[1] Cell Line: HepG2-NTCP cells infected with HBV Concentration: 1 nM-1 μM Incubation Time: 16 h Result: Inhibited viral expression of the surface antigen HBsAg (hepatitis B virus surface antigen) and the core protein HBcAg. |
| References |
| No Any Chemical & Physical Properties |